Back to search

Article

CLUSTER: A biomarker-integrated targeted therapy study in patients with advanced non-small cell lung cancer

2022-07-28

Abstract excerpt

<h4>Purpose: </h4> To better understand the relevance of genomic characteristics of NSCLC for the management of advanced NSCLC in Chinese patients, the phase II CLUSTER umbrella trial simultaneously investigated the efficacy of multiple targeted therapies in Chinese patients with advanced non-small cell lung cancer and pre-specified genetic alterations. <h4>Methods: </h4> CLUSTER was an open-label, umbrella design...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11eb715b-77eb-50f9-b7cf-894ed9fabdd0
DOI
10.21203/rs.3.rs-1359279/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CLUSTER: A biomarker-integrated targeted therapy study in patients with advanced non-small cell lung cancerDOI 10.21203/rs.3.rs-1359279/v2
Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.Semantic proximity
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancerSemantic proximity
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.Semantic proximity
Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinomaSemantic proximity
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.Semantic proximity
Clinical trials and biomarker research on lung cancer in China.Semantic proximity
Molecular Heterogeneity Analysis and Prognostic Stratification of Driver-Gene mutated NSCLC Based on Concurrent Alteration ProfilesSemantic proximity
Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panelSemantic proximity
Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profileSemantic proximity
The Design for a Phase II, Randomized, Multicenter Study of CtDNA-Guided Treatment With Furmonertinib Combined Therapy or Furmonertinib Alone for Untreated Advanced EGFR Mutant Non-small-cell Lung Cancer Patients: The FOCUS-C Study.Semantic proximity
The Role of ERBB4 Mutations in the Prognosis of Advanced Non-small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsSemantic proximity
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancerSemantic proximity
Select a neighboring publication to make it the new centre.